Table 3.
Correlations between serum cytokeratin-18 and some clinical and metabolic characteristics.
| Cytokeratin-18 | ||
|---|---|---|
| r | P | |
| Age (yrs) | 0.031 | ns |
| BMI (kg/m2) | 0.577 | <0.001 |
| Waist circumference | 0.601 | <0.001 |
| HOMA-IR | 0.191 | <0.01 |
| Fasting blood glucose (mg/dL) | 0.216 | <0.01 |
| Total cholesterol (mg/dL) | 0.036 | ns |
| HDL cholesterol (mg/dL) | −0.150 | <0.05 |
| Triglycerides (mg/dL) | 0.100 | ns |
| γ-GT (IU/l) | 0.137 | <0.05 |
| AST (IU/l) | −0.078 | ns |
| ALT (UI/l) | −0.039 | ns |
| Serum ferritin (mg/dL) | −0.106 | ns |
| Serum albumin (mg/dL) | −0.207 | <0.01 |
| Adiponectin | −0.455 | <0.001 |
| Urinary 8-iso-PGF2α (pg/mg creatinine) | 0.607 | <0.001 |
| sNOX2-dp (pg/mL) | 0.451 | <0.001 |
| Hamaguchi score | 0.194 | <0.001 |
| Spleen diameter | 0.190 | <0.05 |
| NAFLD Fibrosis score | 0.299 | <0.001 |
| MetS score | 0.377 | <0.001 |